LIQUID FORMULATIONS WITH HIGH CONCENTRATION OF HUMAN GROWTH HORMONE (HGH) COMPRISING PHENOL

Details for Australian Patent Application No. 2003249992 (hide)

Owner SANDOZ GMBH

Inventors Betz, Michael; Stevens, John

Agent Davies Collison Cave

Pub. Number AU-A-2003249992

PCT Number PCT/EP03/07347

PCT Pub. Number WO2004/004780

Priority 60/394,611 09.07.02 US; 60/394,612 09.07.02 US; 60/394,699 09.07.02 US

Filing date 8 July 2003

Wipo publication date 23 January 2004

International Classifications

A61K 047/00 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 038/27 Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 60/394,611 09.07.02 US; 60/394,612 09.07.02 US; 60/394,699 09.07.02 US

11 March 2004 Application Open to Public Inspection

  Published as AU-A-2003249992

27 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003249993-PHENYL- (4-(3-PHENYL-1H-PYRAZOL-4-YL)-PY RIMIDIN-2-Yl)-AMINE DERIVATIVES

2003249991-Liquid formulations with a high concentration of human growth hormone (high) comprising glycine